Mylan, in crosshairs for spiking cost of EpiPen, says it will expand savings program to cover up to $300, of out of pocket costs

NEW YORK (AP) - Mylan, in crosshairs for spiking cost of EpiPen, says it will expand savings program to cover up to $300, of out of pocket costs.

Mylan, in crosshairs for spiking cost of EpiPen, says it will expand savings program to cover up to $300, of out of pocket costs